[go: up one dir, main page]

WO2007108001A3 - Remodelage de ligament - Google Patents

Remodelage de ligament Download PDF

Info

Publication number
WO2007108001A3
WO2007108001A3 PCT/IL2007/000378 IL2007000378W WO2007108001A3 WO 2007108001 A3 WO2007108001 A3 WO 2007108001A3 IL 2007000378 W IL2007000378 W IL 2007000378W WO 2007108001 A3 WO2007108001 A3 WO 2007108001A3
Authority
WO
WIPO (PCT)
Prior art keywords
remodeling
ligament remodeling
ligament
conforms
diluents
Prior art date
Application number
PCT/IL2007/000378
Other languages
English (en)
Other versions
WO2007108001A2 (fr
Inventor
Haim Dror Blecher
Original Assignee
Haim Dror Blecher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haim Dror Blecher filed Critical Haim Dror Blecher
Publication of WO2007108001A2 publication Critical patent/WO2007108001A2/fr
Publication of WO2007108001A3 publication Critical patent/WO2007108001A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0078—Ultrasound therapy with multiple treatment transducers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Electromagnetism (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition pharmaceutique comprenant un principe actif incluant une quantité physiologiquement efficace d'un agent de remodelage capable de modifier les propriétés d'un ligament jaune (LF), de telle sorte que le LF se conforme à une dimension disponible d'un canal de l'épendyme; l'invention concerne également un vecteur pharmaceutiquement acceptable, des diluants et des excipients.
PCT/IL2007/000378 2006-03-22 2007-03-22 Remodelage de ligament WO2007108001A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78456106P 2006-03-22 2006-03-22
US60/784,561 2006-03-22

Publications (2)

Publication Number Publication Date
WO2007108001A2 WO2007108001A2 (fr) 2007-09-27
WO2007108001A3 true WO2007108001A3 (fr) 2007-12-06

Family

ID=38481926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2007/000378 WO2007108001A2 (fr) 2006-03-22 2007-03-22 Remodelage de ligament

Country Status (1)

Country Link
WO (1) WO2007108001A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037296A1 (fr) * 1998-01-23 1999-07-29 Warner-Lambert Company Gabapentine et ses derives pour le traitement de la douleur musculaire et squelettique
US6684886B1 (en) * 2000-01-21 2004-02-03 Prospine, Inc. Intervertebral disc repair methods and apparatus
JP2004331612A (ja) * 2003-05-09 2004-11-25 Koyo Chemical Kk 腰部脊柱管狭窄症による間歇跛行改善剤
WO2006044727A2 (fr) * 2004-10-15 2006-04-27 Baxano, Inc. Dispositifs et procedes d'ablation de tissus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037296A1 (fr) * 1998-01-23 1999-07-29 Warner-Lambert Company Gabapentine et ses derives pour le traitement de la douleur musculaire et squelettique
US6684886B1 (en) * 2000-01-21 2004-02-03 Prospine, Inc. Intervertebral disc repair methods and apparatus
JP2004331612A (ja) * 2003-05-09 2004-11-25 Koyo Chemical Kk 腰部脊柱管狭窄症による間歇跛行改善剤
WO2006044727A2 (fr) * 2004-10-15 2006-04-27 Baxano, Inc. Dispositifs et procedes d'ablation de tissus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200481, Derwent World Patents Index; AN 2004-817460, XP002453291 *
KIMURA S ET AL: "Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain reliefin relief in degenerative lumbar diseases", PAIN, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 92, no. 3, 2001, pages 363 - 371, XP002975869, ISSN: 0304-3959 *

Also Published As

Publication number Publication date
WO2007108001A2 (fr) 2007-09-27

Similar Documents

Publication Publication Date Title
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
WO2006096434A3 (fr) Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
WO2007027527A3 (fr) Composes d'isoindole-imide et compositions renfermant ceux-ci et procedes d'utilisation de ceux-ci
TWI366460B (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
MX2009004861A (es) Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa.
UA94065C2 (en) Dihydropseudoerythromycin derivatives
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
WO2008136392A1 (fr) Préparation pour une administration orale
EP2316420A8 (fr) Procédé pour réduire la douleur
WO2007009691A3 (fr) Combinaison de substances active s
WO2008128191A3 (fr) Formes dosifiees orales de cephalotaxine
MY144613A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same
WO2008008882A3 (fr) Modulateur du récepteur des glucocorticoïdes et procédés d'utilisation
UA95274C2 (ru) Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления
WO2008004100A3 (fr) Composés thérapeutiques
WO2010029093A3 (fr) Compositions destinées à une administration percutanée
WO2006076097A3 (fr) Preparation non cristalline stable contenant du losartan
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
WO2007108001A3 (fr) Remodelage de ligament
WO2005120518A3 (fr) Utilisation d'analogues d'atp pour le traitement des maladies cardio-vasculaires
AU2016219606A1 (en) Pharmaceutical composition for treating or preventing burn injuries
WO2009108017A3 (fr) Nouveaux dérivés de pyruvate avec effet neuroprotecteur, processus de préparation de ceux-ci et composition pharmaceutique comprenant ces dérivés
TW200716114A (en) Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07713394

Country of ref document: EP

Kind code of ref document: A2